Drug
safety advice |
|
Yasmin:
update on risk of venous thromboembolism |
|
Clopidogrel
and proton pump inhibitors: interaction - updated advice |
|
Intravenous
zoledronic acid: adverse effects on renal function |
|
Parenteral
amphotericin B: fatal overdose risk due to confusion between lipid-based
and non-lipid-based formulations |
|
Rifadin
infusion (rifampicin): new solvent formulation and changes to compatible
diluents |
Stop
Press |
|
Becaplermin
(Regranex) for diabetic ulcers: contraindicated in patients with any
known current cancer |
Other
information from the MHRA |
|
MHRA
conference for doctors in training |
|
Patient
information leaflet of the month: Methotrexate Tablets |